Preclinical and Clinical Investigations of Mood Stabilizers for Huntington's Disease: What Have We Learned?

Huntington's disease (HD) is a lethal, autosomal dominant neurodegenerative disorder caused by CAG repeat expansions at exon 1 of the huntingtin (Htt) gene, which encodes for a mutant huntingtin protein (mHtt). Prominent symptoms of HD include motor dysfunction, characterized by chorea; psychia...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheuing, Lisa, Chiu, Chi-Tso, Liao, Hsiao-Mei, Linares, Gabriel R., Chuang, De-Maw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183923/
https://www.ncbi.nlm.nih.gov/pubmed/25285035
http://dx.doi.org/10.7150/ijbs.9898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183923/
https://www.ncbi.nlm.nih.gov/pubmed/25285035
http://dx.doi.org/10.7150/ijbs.9898

Ejemplares similares